FDA Grants AstraZeneca Priority Review for Sonesitatug Vedotin
The FDA accepted AstraZeneca’s biologics license application for sonesitatug vedotin and granted Priority Review for second- and l
The FDA accepted AstraZeneca’s biologics license application for sonesitatug vedotin and granted Priority Review for second- and l